HC Wainwright & Co. Maintains Buy on LB Pharmaceuticals, Raises Price Target to $60

HC Wainwright & Co. analyst Raghuram Selvaraju maintains LB Pharmaceuticals (NASDAQ:LBRX) with a Buy and raises the price target from $45 to $60.